IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
63 hedge funds and large institutions have $22.6M invested in IVERIC bio, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 11 closing their positions.
451% more call options, than puts
Call options by funds: $248K | Put options by funds: $45K
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
7% less funds holding
Funds holding: 68 → 63 (-5)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
38% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 24
50% less capital invested
Capital invested by funds: $44.9M → $22.6M (-$22.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.39M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.16M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$811K |
| 4 |
JP Morgan Chase
New York
|
+$183K |
| 5 |
Two Sigma Investments
New York
|
+$175K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$2.57M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.25M |
| 3 |
Man Group
London,
United Kingdom
|
-$393K |
| 4 |
EP
Eversept Partners
New York
|
-$352K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$295K |
ISEE Hedge Fund Activity: Q4 2018 in Review
63 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2018, worth a combined $22.6M — down 50% from $44.9M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ISEE and 7 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 15 added.
The largest buyer was Stonepine Capital Management, adding an estimated $3.39M. The largest seller was AJO LP, exiting entirely with an estimated $2.57M sold.
- 63 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2018, down from 68 in Q3 2018.
- Funds reported $22.6M of IVERIC bio, Inc. Common Stock stock for Q4 2018, down 50% quarter-over-quarter.
- 7 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2018 and 11 closed out, a net change of -4 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q4 2018 was Stonepine Capital Management, an estimated $3.39M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q4 2018 was AJO LP, an estimated $2.57M sold.
Based on aggregated 13F filings for Q4 2018.